alexa
Indianmoney.com Missed Call Number
 
Home News J&J revenue misses on lower-than-expected pharmaceutical sales

Read more interesting news from around the globe with Indianmoney App

Google Play
 
J&J revenue misses on lower-than-expected pharmaceutical sales

J&J revenue misses on lower-than-expected pharmaceutical sales

Tuesday, April 18, 2017, 5:27 PM

Johnson & Johnson, which is in the process of completing its $30 billion acquisition of Swiss biotech Actelion, reported quarterly revenue that missed analysts' estimates, hurt by lower demand for its pharmaceutical products. The diversified healthcare company's sales rose to $17.77 billion in the first-quarter from $17.48 billion a year earlier, but came in below analysts' average estimate of $18.04 billion, according to reports.
Read More

Learn to Save, Spend, Invest & Borrow Wisely with our Youtube Channel

Get It now!